![](/img/cover-not-exists.png)
Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: six-month analysis
H. Eisen, R. Dorent, D. Mancini, H. Valantine, M. Vigano, R. Starling, J. Lind, P. Bernhardt, K. AbeywickramaVolume:
21
Year:
2002
Language:
english
DOI:
10.1016/s1053-2498(01)00435-1
File:
PDF, 67 KB
english, 2002